Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Freeport-McMoRan Inc (FCX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Freeport-McMoRan Inc — how do they compare? Definium Therapeutics Inc. Common Shares trades at $36.8 (market cap $4.59B), while Freeport-McMoRan Inc trades at $73.55 (market cap $102.16B). The key difference: Freeport-McMoRan Inc is far larger — about 22.3× Definium Therapeutics Inc. Common Shares's market cap, and Freeport-McMoRan Inc pays a 0.84% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Freeport-McMoRan Inc for 69 Days on average.
| DFTX | FCX | |
|---|---|---|
Market Cap | $4.59B | $102.16B |
Volume | 2,103,937 | 9,047,971 |
Sector | Health | Basic Materials |
52-Week High | $48.45 | $79.91 |
52-Week Low | $10.68 | $38.65 |
Typical Hold Time | 0 Days | 69 Days |
Enterprise Value | $3.55B | $108.44B |
Dividend Yield | — | 0.84% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Freeport-McMoRan (FCX) trades at $73.69, up 2.54% with strong earnings momentum after beating estimates for three consecutive quarters. The stock shows bearish technical signals but maintains solid fundamentals with $25.9B revenue, 11.38% net margin, and positive cash flow trends. Recent news highlights copper demand growth from AI/data centers, positioning FCX to benefit from favorable commodity trends while managing cost pressures.
FCX presents a mixed outlook with analyst consensus at Buy (61%) and $73.27 price target near current levels. Upside potential exists from copper's structural deficit and expansion projects, but risks include rising production costs, margin pressure, and ongoing legal investigation. The stock offers exposure to copper's AI-driven demand while facing execution challenges in a volatile commodity environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Freeport-McMoRan Inc
Freeport-McMoRan Inc is an international mining company. It operates geographically diverse assets with proven and probable mineral reserves of copper, gold and molybdenum. The company's portfolio of assets includes the Grasberg minerals district in Indonesia
Read more on FCX →
